Results 21 to 30 of about 20,680 (257)
Indian Journal of Dermatology, 2010 Pityriasis rosea is a frequent papulo-squamous disease and is known for various atypical clinical presentations. We report an adult female patient with a clinical diagnosis of giant pityriasis rosea, which is a rarity in clinical practice.
Zawar Vijay
doaj +4 more sources
Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature. [PDF]
Dermatol Reports, 2023 Only a few cases of pityriasis rosea (PR)/pityriasis rosea-like eruption (PRLE) after anti-SARS-CoV-2 vaccination have been reported. In the period May 2021- February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after ...
Veraldi S +3 more
europepmc +2 more sources
Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl. [PDF]
Cureus, 2022 Pityriasis rosea (PR) is an acute self-limiting exanthematous skin disorder characterized by the presence of a primary solitary lesion called a herald patch and the subsequent development of diffuse papulosquamous lesions within 1 to 2 weeks.
Bin Rubaian NF +3 more
europepmc +2 more sources
COVID-19-associated pityriasis rosea in children: Case report and literature review. [PDF]
Clin Case Rep, 2022 Skin lesions are one of the Coronavirus disease 2019 (COVID‐19) symptoms. Pityriasis rosea (PR) is a mucocutaneous manifestation that can occur following virus infections. Most of the PR lesions after COVID‐19 infection were reported in adults.
Khalili M +3 more
europepmc +2 more sources
InnovAiT: Education and inspiration for general practicePityriasis rosea is a benign self-limiting rash, usually lasting 6 to 8 weeks. In classic pityriasis rosea a ‘herald patch’ is the initial finding, a large oval patch usually found on the torso.
Litchman G, Nair PA, Syed HA, Le JK.
europepmc +2 more sources
Balkan Medical Journal, 2013 Background: Pityriasis rosea is an acute inflamatory skin disease that the etiology is unknown but some viral agents like human herpes virus-6 and 7 and drugs are suspected. Case report: A-58-year-old man with chronic hepatitis C was being followed up
Rahmet Güner +3 more
doaj +2 more sources
Pityriasis rosea: a distinct entity or viral exanthem?
Przegląd DermatologicznyPityriasis rosea is a well-known, common skin dermatosis in clinical practice. It has a benign self-limiting character and most often does not require any treatment. It is probably caused by reactivation of the human herpes virus-6 and -7.
Natalia Dąbrowska +9 more
doaj +2 more sources
Pityriasis rosea, COVID‐19 and vaccination: new keys to understand an old acquaintance
Journal of the European Academy of Dermatology and Venereology, 2021 Lately we have witnessed sporadic reports of Pityriasis Rosea (PR) and PR-like eruptions associated with SARS-CoV-2. Such relationship has raised debate on the possible etiopathogenic mechanism underlying this exanthematous disease.
José Manuel Busto‐Leis +7 more
openalex +2 more sources
Line-field confocal optical coherence tomography assessment of pityriasis rosea. [PDF]
JAAD Case Rep, 2023 Pathak GN, Truong TM, Rao BK.
europepmc +2 more sources
Nomenclature of drug-induced pityriasis rosea-like rashes
Neuropsychiatric Disease and Treatment, 2015 Antonio AT Chuh1Prince of Wales Hospital, Hospital Authority, 2The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong KongI read with admiration an article published in your ...
Chuh AAT
doaj +3 more sources